EPISODE · Nov 28, 2023 · 8 MIN
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
from NeuroFrontiers
Host: Andrew Wilner, MD, FACP, FAAN Guest: William A. Kilgo, MD According to new research featured at the joint ECTRIMS-ACTRIMS meeting, the Multiple Sclerosis Disease Activity (MSDA) Test is a reliable indicator of recent objective disease activity when used within an academic clinic. Based on these findings, Dr. Andrew Wilner sits down with lead author of the study, Dr. William Kilgo, to discuss how the MSDA can be applied in our real-world clinical practice.
Embed this episode
Ready to play
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
No transcript for this episode yet
Similar Episodes
No similar episodes found.